Literature DB >> 8789777

Successful treatment of heart failure with enoximone in a patient with cytochrome c oxidase deficiency.

A Timnik, S Mühlbauer, A Merkenschlager, K Reiter, W Lindner, J Paetzke, B Obermaier-Kusser, A Roscher, T Nicolai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8789777     DOI： 10.1007/bf01955199

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

Review 1.  Pharmacology of positive inotropic phosphodiesterase III inhibitors.

Authors:  P Honerjäger
Journal:  Eur Heart J       Date:  1989-08       Impact factor: 29.983

2.  Myocardial beta-adrenergic receptor downregulation in heart failure.

Authors:  M R Bristow
Journal:  Int J Cardiol       Date:  1984-05       Impact factor: 4.164

Review 3.  Cytochrome c oxidase deficiency.

Authors:  S DiMauro; A Lombes; H Nakase; S Mita; G M Fabrizi; H J Tritschler; E Bonilla; A F Miranda; D C DeVivo; E A Schon
Journal:  Pediatr Res       Date:  1990-11       Impact factor: 3.756

4.  Addition of enoximone to adrenergic agents in the management of severe heart failure.

Authors:  J L Vincent; M Léon; J Berré; C Mélot; R J Kahn
Journal:  Crit Care Med       Date:  1992-08       Impact factor: 7.598

5.  Anesthesia in pediatric heart transplantation.

Authors:  B Zickmann; J Boldt; G Hempelmann
Journal:  J Heart Lung Transplant       Date:  1992 Jul-Aug       Impact factor: 10.247

Review 6.  [Value of phosphodiesterase inhibitors in anesthesia and intensive care].

Authors:  J Boldt; H Hammermann; G Hempelmann
Journal:  Z Kardiol       Date:  1994

7.  Enoximone in newborns with refractory postoperative low-output states (LOS).

Authors:  G Hausdorf; N Friedel; F Berdjis; H A Dieterich; J J Fell; H T Dressler; A Werneyer; R Hetzer; P E Lange
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.